Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Saxenda (liraglutide) frequently causes constipation because it slows gastric emptying, reduces gut motility, and often lowers fluid and fiber intake. Most cases can be managed with:
If these strategies don't work or symptoms significantly affect your quality of life, talk with your doctor about alternative GLP-1 receptor agonists or other weight-loss medications.
Red flags such as severe abdominal pain, vomiting, blood in stool, or inability to pass gas require prompt medical attention.
Because constipation on Saxenda can range from a mild side effect to a sign of something more serious, understanding your specific symptoms matters. Take a free, instant, online symptom check to clarify what may be driving your discomfort and get personalized guidance on what to do next.
Reviewed for medical accuracy: 07/10/2026
Saxenda (liraglutide) is a popular prescription medication for weight management. As a GLP-1 receptor agonist, it works by slowing gastric emptying and reducing appetite. While many people find it effective, one common side effect is constipation. This guide explains why Saxenda causes constipation, how to manage it, and when you might consider switching medications.
Understanding the underlying mechanisms can help you manage this side effect:
Slowed Gastric Emptying
Saxenda delays the movement of food from the stomach to the small intestine. While this promotes fullness, it also:
Altered Gut Motility
GLP-1 receptors are found throughout the gut. When activated, they:
Reduced Caloric and Fluid Intake
Eating less often means:
Individual Sensitivity
Not everyone reacts the same way. Factors that increase your risk of Saxenda-related constipation include:
In clinical trials, about 5–20% of Saxenda users reported constipation. It often appears within the first few weeks of starting treatment or after a dosage increase.
Symptoms may range from mild to severe. Watch for:
If you're experiencing these symptoms and want personalized insights about what might be causing them, check your symptoms with Ubie's free AI symptom checker and receive a detailed report in just 3 minutes.
Most people can manage constipation with lifestyle tweaks and over-the-counter options. Here's what to try first:
Increase fiber intake gradually to 25–35 grams per day:
Adequate fluids (1.5–2 liters daily) help soften stool:
Exercise stimulates intestinal motility:
If lifestyle changes aren't enough, these options can provide relief:
Important: Always follow dosing instructions and avoid mixing multiple laxatives without medical advice.
If constipation significantly affects your quality of life or persists despite your best efforts, discuss alternatives with your doctor. Consider:
Some people tolerate other medications better:
If GLP-1 agonists aren't tolerable, alternatives include:
Switching should be a shared decision with your healthcare provider, weighing benefits, side effects, and your personal goals.
Constipation is common, but certain signs require urgent attention:
If you experience any of these symptoms, speak to a doctor right away.
Constipation from Saxenda is uncomfortable but often manageable with diet, hydration, exercise, and judicious use of over-the-counter remedies. If symptoms persist or worsen, it's worth exploring other medications under medical supervision. Before your next doctor's appointment, use Ubie's free AI-powered symptom checker to evaluate your symptoms and receive personalized insights that can help you have a more informed conversation with your healthcare provider.
Always discuss any serious or life-threatening issues with your healthcare provider. Your doctor can help tailor a safe, effective weight-loss plan that minimizes side effects and supports your overall health.
(References)
* Sheng C, Hou C, Zhang T, Huang J, Xu Y. Safety and Tolerability of Liraglutide and Tirzepatide in Type 2 Diabetes. Drug Des Devel Ther. 2023 Feb 1;17:347-360. doi: 10.2147/DDDT.S397500. PMID: 36761189.
* Wang T, Zhang Q, Zhao M, et al. Gastrointestinal adverse events with GLP-1 receptor agonists in patients with type 2 diabetes mellitus: A meta-analysis. Front Pharmacol. 2022 Dec 12;13:1086054. doi: 10.3389/fphar.2022.1086054. PMID: 36570659.
* Hussain M, Ahmad R, Mahmood T, et al. Mechanisms of nausea, vomiting, and constipation in GLP-1 receptor agonist-induced gastrointestinal side effects. Eur J Pharmacol. 2024 Jan 15;963:170068. doi: 10.1016/j.ejphar.2023.170068. PMID: 38096956.
* Chekuri S, Shah A, Shah N, et al. Management of Gastrointestinal Side Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. J Clin Gastroenterol. 2023 Nov 1;57(10):1038-1044. doi: 10.1097/MCG.0000000000001923. PMID: 37494451.
* Shi M, Chen W, Pan G, Zhao S. Comparative Efficacy and Safety of GLP-1 Receptor Agonists for Type 2 Diabetes: A Network Meta-Analysis. Int J Endocrinol. 2022 Aug 30;2022:9239556. doi: 10.1155/2022/9239556. PMID: 36097723.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.